UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 80 filers reported holding UROGEN PHARMA LTD in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $768,000 | +8.2% | 39,400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $710,000 | -8.4% | 39,400 | -2.0% | 0.00% | 0.0% |
| Q3 2020 | $775,000 | -24.3% | 40,200 | +2.6% | 0.00% | 0.0% |
| Q2 2020 | $1,024,000 | +37.1% | 39,200 | -6.4% | 0.00% | 0.0% |
| Q1 2020 | $747,000 | -37.6% | 41,898 | +16.7% | 0.00% | 0.0% |
| Q4 2019 | $1,198,000 | +159.3% | 35,900 | +85.1% | 0.00% | – |
| Q3 2019 | $462,000 | -14.9% | 19,400 | +28.5% | 0.00% | -100.0% |
| Q2 2019 | $543,000 | +6.5% | 15,100 | +9.4% | 0.00% | 0.0% |
| Q1 2019 | $510,000 | -14.1% | 13,800 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $594,000 | -18.6% | 13,800 | -10.7% | 0.00% | 0.0% |
| Q3 2018 | $730,000 | -13.1% | 15,462 | -8.4% | 0.00% | 0.0% |
| Q2 2018 | $840,000 | – | 16,885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |